Not at all. Trial and BLA was always up to 18. You often hear comments regarding the under 12 group because they have no approved treatment options.
- Forums
- ASX - By Stock
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Not at all. Trial and BLA was always up to 18. You often hear...
-
-
- There are more pages in this discussion • 294 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
97.5¢ |
Change
0.005(0.52%) |
Mkt cap ! $1.107B |
Open | High | Low | Value | Volume |
96.5¢ | 97.5¢ | 96.5¢ | $231.2K | 239.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 22117 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 40711 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 51908 | 0.970 |
9 | 97630 | 0.965 |
11 | 134957 | 0.960 |
9 | 128277 | 0.955 |
8 | 158854 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.980 | 34235 | 4 |
0.985 | 98584 | 5 |
0.990 | 98825 | 9 |
0.995 | 140538 | 4 |
1.000 | 145022 | 11 |
Last trade - 10.05am 26/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online